Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)

NCT00230971 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

473

Enrollment

INDUSTRY

Sponsor class

Conditions

Appendicitis
Cholecystitis
Diverticulitis
Intra-Abdominal Abscess
Intra-Abdominal Infection
Peritonitis

Interventions

DRUG: tigecycline
DRUG: ceftriaxone plus metronidazole

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer